p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan

被引:0
|
作者
Lunn, RM
Zhang, YJ
Wang, LY
Chen, CJ
Lee, PH
Lee, CS
Tsai, WY
Santella, RM
机构
[1] COLUMBIA UNIV,SCH PUBL HLTH,DIV ENVIRONM HLTH SCI,NEW YORK,NY 10032
[2] COLUMBIA UNIV,SCH PUBL HLTH,DIV BIOSTAT,NEW YORK,NY 10032
[3] NATL TAIWAN UNIV,COLL PUBL HLTH,GRAD INST EPIDEMIOL,TAIPEI 10764,TAIWAN
[4] NATL TAIWAN UNIV,COLL MED,DEPT SURG,TAIPEI 10018,TAIWAN
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent studies have implicated aflatoxin B-1 (AFB(1)) exposure as an etiological agent in hepatocellular carcinoma (HCC) and suggested an interaction with chronic hepatitis B virus (HBV) infection, Worldwide AFB, exposure correlates with a specific mutation at codon 249 in the p53 tumor suppressor gene in liver tumors. This study investigated the roles of HBV and AFB(1) in the HCC carcinogenic pathway involving p53 mutations, In cases and controls, chronic HBV infection was assessed by serum hepatitis B surface antigen (HBsAg) and AFB(1) exposure by immunohistochemical detection of AFB(1)-DNA adduct in liver tissue. p53 protein mutations in tumor tissues of HCC cases mere identified by immunohistochemistry and DNA mutations by single-stranded conformational polymorphism and sequencing analysis, Both chronic HBsAg carrier status and liver AFB(1)-DNA adducts were significantly higher in cases than in controls with odds ratios (OR) of 8.4 and 3.9, respectively (P < 0.01), Moreover, HCC risk was greatest in individuals with both AFB(1)-DNA adducts and HBsAg, suggesting a viral-chemical interaction, Mutant p53 protein, mutations in the p53 gene, and specific codon 249 mutations were detected in 37, 29, and 13%, respectively, of the HCC cases, Most of the DNA mutations were transversions, and the only major clustering site for mutations was codon 249. AFB(1)-DNA adducts were associated with p53 protein (OR = 2.9, P = 0.054) and DNA mutations (OR = 2.9, P = 0.082) but with borderline significance, All of the codon 249 mutations (n = 12) occurred in HBsAg-seropositive carriers, resulting in an OR of 10.0 (P < 0.05), suggesting that HBV may be involved in the selection of these mutations, The ORs between HBsAg and p53 DNA and protein mutations were 2.6 (P = 0.077) and 1.8 (P > 0.05), respectively, Both p53 DNA and protein mutations were related to tumor stage, suggesting that they are late events, These studies provided further support for the role of aflatoxin exposure in HCC in Taiwan and insight into viral-chemical interactions and molecular pathogenesis.
引用
收藏
页码:3471 / 3477
页数:7
相关论文
共 50 条
  • [1] Aflatoxin B1 Exposure, Hepatitis B Virus Infection, and Hepatocellular Carcinoma in Taiwan
    Wu, Hui-Chen
    Wang, Qiao
    Yang, Hwai-I
    Ahsan, Habibul
    Tsai, Wei-Yann
    Wang, Li-Yu
    Chen, Shu-Yuan
    Chen, Chien-Jen
    Santella, Regina M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (03) : 846 - 853
  • [2] The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure
    Qi, Lu-Nan
    Bai, Tao
    Chen, Zu-Shun
    Wu, Fei-Xiang
    Chen, Yuan-Yuan
    Xiang, Bang-De
    Peng, Tao
    Han, Ze-Guang
    Li, Le-Qun
    LIVER INTERNATIONAL, 2015, 35 (03) : 999 - 1009
  • [3] MUTATIONS OF P53 GENE IN HEPATOCELLULAR-CARCINOMA - ROLES OF HEPATITIS-B VIRUS AND AFLATOXIN CONTAMINATION IN THE DIET
    HSIA, CC
    KLEINER, DE
    AXIOTIS, CA
    DIBISCEGLIE, A
    NOMURA, AMY
    STEMMERMANN, GN
    TABOR, E
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (21) : 1638 - 1641
  • [4] P53 MUTATIONS AND HEPATITIS-B VIRUS - COFACTORS IN HEPATOCELLULAR-CARCINOMA
    SLAGLE, BL
    HEPATOLOGY, 1995, 21 (02) : 597 - 599
  • [5] Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1
    Park, US
    Su, JJ
    Ban, KC
    Qin, LL
    Lee, EH
    Lee, YI
    GENE, 2000, 251 (01) : 73 - 80
  • [6] Hepatitis B and C virus infection and p53 mutations in human hepatocellular carcinoma in Harbin, Heilongjian Province, China
    Jin, Y
    Abe, KJ
    Sato, Y
    Aita, K
    Irie, H
    Shiga, J
    HEPATOLOGY RESEARCH, 2002, 24 (04) : 379 - 384
  • [7] P53 MUTATIONS AND AFLATOXIN-B1 EXPOSURE IN HEPATOCELLULAR-CARCINOMA PATIENTS FROM THAILAND
    HOLLSTEIN, MC
    WILD, CP
    BLEICHER, F
    CHUTIMATAEWIN, S
    HARRIS, CC
    SRIVATANAKUL, P
    MONTESANO, R
    INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (01) : 51 - 55
  • [8] Urinary 8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan
    Wu, Hui-Chen
    Wang, Qiao
    Wang, Lian-Wen
    Yang, Hwai-I
    Ahsan, Habibul
    Tsai, Wei-Yann
    Wang, Li-Yu
    Chen, Shu-Yuan
    Chen, Chien-Jen
    Santella, Regina M.
    CARCINOGENESIS, 2007, 28 (05) : 995 - 999
  • [9] P53 MUTATION IN HEPATOCELLULAR-CARCINOMA AFTER AFLATOXIN EXPOSURE
    OZTURK, M
    LANCET, 1991, 338 (8779): : 1356 - 1359
  • [10] MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
    Yoon, Young Joon
    Chang, Hye Young
    Ahn, Sang Hoon
    Kim, Ja Kyung
    Park, Yong Kwang
    Kang, Dae Ryong
    Park, Jun Yong
    Myoung, Sung Min
    Kim, Do Young
    Chon, Chae Yoon
    Han, Kwang-Hyub
    CARCINOGENESIS, 2008, 29 (06) : 1192 - 1196